Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Europa
Edwards Lifesciences Corp
Nieuws
Edwards Lifesciences Corp
EWL
XET
: EWL
| ISIN: US28176E1082
12/11/2024
61,45 EUR
(-2,29%)
(-2,29%)
12/11/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
3 juni 2024 ·
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
· Persbericht
26 oktober 2023 ·
Clasp Iid One-Year Data Confirm Safety And Efficacy Of Edwards Pascal System For Degenerative Mitral Regurgitation
· Persbericht
26 oktober 2023 ·
Triscend Ii Six-Month Data For First 150 Patients Successfully Demonstrate Safety And Efficacy Of Edwards Evoque System For Severe Tricuspid Regurgitation
· Persbericht
25 oktober 2023 ·
Edwards Lifesciences Reports Third Quarter Results
· Persbericht
24 oktober 2023 ·
Five-Year Data From Partner 3 Trial Demonstrate Excellent Survival For Patients Receiving Edwards Sapien 3 Valve
· Persbericht
19 oktober 2023 ·
Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives Ce Mark
· Persbericht
18 oktober 2023 ·
Edwards Lifesciences To Host Earnings Conference Call On October 25, 2023
· Persbericht
29 augustus 2023 ·
BetterInvesting™ Magazine Update on Edwards Lifesciences Corp. and 3M Company
· Persbericht
28 augustus 2023 ·
Edwards Lifesciences To Present At The 2023 Wells Fargo Healthcare Conference
· Persbericht
26 juli 2023 ·
Edwards Lifesciences Reports Second Quarter Results
· Persbericht
19 juli 2023 ·
Edwards Lifesciences To Host Earnings Conference Call On July 26, 2023
· Persbericht
17 mei 2023 ·
Data From Benchmark Registry Demonstrate Improved Tavr Efficiency With Preserved Patient Safety
· Persbericht
8 mei 2023 ·
Edwards' Aortic Valve With Resilia Tissue Shows Favorable Durability, Safety And Efficacy Outcomes In Seven Year Data
· Persbericht
26 april 2023 ·
Edwards Lifesciences Reports First Quarter Results
· Persbericht
19 april 2023 ·
Edwards Lifesciences To Host Earnings Conference Call On April 26, 2023
· Persbericht
6 maart 2023 ·
Edwards Highlights New Data At Acc Related To Lifetime Management Of Aortic Stenosis
· Persbericht
31 januari 2023 ·
Edwards Lifesciences Reports Fourth Quarter Results
· Persbericht
24 januari 2023 ·
Edwards Lifesciences To Host Earnings Conference Call On January 31, 2023
· Persbericht
5 januari 2023 ·
Edwards Lifesciences To Present At The 41St Annual J.p. Morgan Healthcare Conference
· Persbericht
8 december 2022 ·
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe